220 related articles for article (PubMed ID: 34448248)
21. Successful treatment of CARD14-negative juvenile Pityriasis rubra pilaris with Ustekinumab.
Reitmajer M; Forchhammer S; Silber T
J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):e512-e514. PubMed ID: 38084925
[No Abstract] [Full Text] [Related]
22. Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options.
Joshi TP; Duvic M
Am J Clin Dermatol; 2024 Mar; 25(2):243-259. PubMed ID: 38159213
[TBL] [Abstract][Full Text] [Related]
23. Familial pityriasis rubra pilaris in a Chinese family caused by a novel mutation in CARD14 gene.
Wu T; Banerjee S; Deng J; Wu J; Huang H; Zheng H; Pan H; Wang Y; Peng Z; Sun X
Indian J Dermatol Venereol Leprol; 2020; 86(1):81-84. PubMed ID: 31755479
[No Abstract] [Full Text] [Related]
24. Increased epidermal expression and absence of mutations in CARD14 in a series of patients with sporadic pityriasis rubra pilaris.
Eytan O; Qiaoli L; Nousbeck J; van Steensel MA; Burger B; Hohl D; Taïeb A; Prey S; Bachmann D; Avitan-Hersh E; Jin Chung H; Shemer A; Trau H; Bergman R; Fuchs-Telem D; Warshauer E; Israeli S; Itin PH; Sarig O; Uitto J; Sprecher E
Br J Dermatol; 2014 May; 170(5):1196-8. PubMed ID: 24359224
[No Abstract] [Full Text] [Related]
25. Analysis of CARD14 Polymorphisms in Pityriasis Rubra Pilaris: Activation of NF-κB.
Li Q; Jin Chung H; Ross N; Keller M; Andrews J; Kingman J; Sarig O; Fuchs-Telem D; Sprecher E; Uitto J
J Invest Dermatol; 2015 Jul; 135(7):1905-1908. PubMed ID: 25734815
[No Abstract] [Full Text] [Related]
26. Target-sequence Capture and High Throughput Sequencing Identify a De novo CARD14 Mutation in an Infant with Erythrodermic Pityriasis Rubra Pilaris.
Has C; Schwieger-Briel A; Schlipf N; Hausser I; Chmel N; Rösler B; Technau K; Jakob T; Zimmer A; Fischer J
Acta Derm Venereol; 2016 Nov; 96(7):989-990. PubMed ID: 27140437
[No Abstract] [Full Text] [Related]
27. Genetic analysis of CARD14 in non-familial pityriasis rubra pilaris: a case series.
Hong JB; Chen PL; Chen YT; Tsai TF
Acta Derm Venereol; 2014 Sep; 94(5):587-8. PubMed ID: 24577624
[No Abstract] [Full Text] [Related]
28. Altered replication stress response due to CARD14 mutations promotes recombination-induced revertant mosaicism.
Miyauchi T; Suzuki S; Takeda M; Peh JT; Aiba M; Natsuga K; Fujita Y; Takeichi T; Sakamoto T; Akiyama M; Shimizu H; Nomura T
Am J Hum Genet; 2021 Jun; 108(6):1026-1039. PubMed ID: 34004138
[TBL] [Abstract][Full Text] [Related]
29. [Molecular identification of the PSORS2 locus: mutations and polymorphisms in CARD14 gene].
Dereure O
Ann Dermatol Venereol; 2013 Jan; 140(1):65-6. PubMed ID: 23328365
[No Abstract] [Full Text] [Related]
30. Immune-regulatory genes as possible modifiers of familial pityriasis rubra pilaris - lessons from a family with PRP and psoriasis.
Spoerri I; Herms S; Eytan O; Sarig O; Heinimann K; Sprecher E; Itin PH; Burger B
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):e389-e392. PubMed ID: 29704870
[No Abstract] [Full Text] [Related]
31. Pityriasis rubra pilaris with erythema gyratum repens-like eruption and resolution with ustekinumab.
Wong JY; Surgenor L; McCourt C
Clin Exp Dermatol; 2022 Dec; 47(12):2300-2303. PubMed ID: 35978553
[TBL] [Abstract][Full Text] [Related]
32. Clinical response to ustekinumab in CARD14-associated papulosquamous eruption (CAPE) with a new missense mutation in CARD14: a case report and systematic review.
Nieto-Benito LM; Baniandrés-Rodríguez O; Moreno-Torres A; Hernández-Martín A; Torrelo-Fernández A; Campos-Domínguez M
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):e728-e730. PubMed ID: 32349169
[No Abstract] [Full Text] [Related]
33. A Review on Pityriasis Rubra Pilaris.
Wang D; Chong VC; Chong WS; Oon HH
Am J Clin Dermatol; 2018 Jun; 19(3):377-390. PubMed ID: 29302927
[TBL] [Abstract][Full Text] [Related]
34. Treatment Options for Juvenile Pityriasis Rubra Pilaris.
Guenther J; Novack D; Kamath S; Worswick S
Paediatr Drugs; 2023 Mar; 25(2):151-164. PubMed ID: 36529810
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin.
Katharina M; Sylvia S; Matthias B; Ulrich M; Martin L
Pediatr Dermatol; 2022 Jul; 39(4):659-661. PubMed ID: 35859269
[TBL] [Abstract][Full Text] [Related]
36. Case report: Successful treatment with biologics in a pediatric patient with a severe inflammatory skin disease and novel
Niedźwiedź M; Narbutt J; Siekierko A; Skibińska M; Kwiek B; Sobolewska-Sztychny D; Ciążyńska M; Poznańska-Kurowska K; Gostyński A; Lesiak A
Front Med (Lausanne); 2024; 11():1360248. PubMed ID: 38375322
[No Abstract] [Full Text] [Related]
37. Epithelioid cell granuloma formation in CARD14-associated papulosquamous eruptions.
Takeichi T; Ikeda K; Muro Y; Ogi T; Morizane S; Akiyama M
J Eur Acad Dermatol Venereol; 2022 May; 36(5):e369-e371. PubMed ID: 34927775
[No Abstract] [Full Text] [Related]
38. Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris.
Berki DM; Liu L; Choon SE; David Burden A; Griffiths CEM; Navarini AA; Tan ES; Irvine AD; Ranki A; Ogo T; Petrof G; Mahil SK; Duckworth M; Allen MH; Vito P; Trembath RC; McGrath J; Smith CH; Capon F; Barker JN
J Invest Dermatol; 2015 Dec; 135(12):2964-2970. PubMed ID: 26203641
[TBL] [Abstract][Full Text] [Related]
39. Two cases of CARD14-associated papulosquamous eruption from India.
Chiramel MJ; Sathishkumar D; Edison ES; George R
Pediatr Dermatol; 2020 Jul; 37(4):692-694. PubMed ID: 32323375
[TBL] [Abstract][Full Text] [Related]
40. Autoinflammatory keratinization diseases: An emerging concept encompassing various inflammatory keratinization disorders of the skin.
Akiyama M; Takeichi T; McGrath JA; Sugiura K
J Dermatol Sci; 2018 May; 90(2):105-111. PubMed ID: 29422292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
